{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:46:07Z","timestamp":1772793967207,"version":"3.50.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR-SFB43"],"award-info":[{"award-number":["TRR-SFB43"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RK-Grant FL 377\/3-1"],"award-info":[{"award-number":["RK-Grant FL 377\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Science and Culture of Lower Saxony","award":["ZN2871"],"award-info":[{"award-number":["ZN2871"]}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01Gl1209"],"award-info":[{"award-number":["01Gl1209"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006259","name":"TEVA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.nbd.2017.02.002","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T16:18:02Z","timestamp":1487780282000},"page":"60-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Laquinimod enhances central nervous system barrier functions"],"prefix":"10.1016","volume":"102","author":[{"given":"Fred","family":"L\u00fchder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hania","family":"Kebir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Odoardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Litke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maike","family":"Sonneck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Ivan","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Winchenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liat","family":"Hayardeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ella","family":"Sorani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitri","family":"Lodygin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Fl\u00fcgel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Prat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2017.02.002_bb0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jneuroim.2012.06.005","article-title":"Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis","volume":"251","author":"Aharoni","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0010","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1126\/science.1206936","article-title":"The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence","volume":"334","author":"Alvarez","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.nbd.2017.02.002_bb0015","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/glia.22575","article-title":"Glial influence on the blood brain barrier","volume":"61","author":"Alvarez","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2017.02.002_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nbd.2014.09.016","article-title":"Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions","volume":"74","author":"Alvarez","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2017.02.002_bb0025","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1440-1711.1998.00709.x","article-title":"Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements","volume":"76","author":"Barnden","year":"1998","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature08478","article-title":"Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions","volume":"462","author":"Bartholom\u00e4us","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2017.02.002_bb0035","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1084\/jem.20021603","article-title":"Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis","volume":"197","author":"Bettelli","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2017.02.002_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jns.2011.02.019","article-title":"Insight into the mechanism of laquinimod action","volume":"306","author":"Br\u00fcck","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2017.02.002_bb0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00401-012-1009-1","article-title":"Reduced astrocytic NF-kappaB activation by laquinimod protects from cuprizone-induced demyelination","volume":"124","author":"Br\u00fcck","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-5728(02)00225-4","article-title":"The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis","volume":"130","author":"Brunmark","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0055","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ni1551","article-title":"Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system","volume":"9","author":"Cayrol","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0060","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1056\/NEJMoa1104318","article-title":"Placebo-controlled trial of oral laquinimod for multiple sclerosis","volume":"366","author":"Comi","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2017.02.002_bb0065","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/brain\/awq135","article-title":"Nicotinic acid adenine dinucleotide phosphate-mediated calcium signalling in effector T cells regulates autoimmunity of the central nervous system","volume":"133","author":"Cordiglieri","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2017.02.002_bb0070","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1474-4422(09)70275-3","article-title":"Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score","volume":"8","author":"De Jager","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0075","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/jnnp-2013-306132","article-title":"Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage","volume":"85","author":"Filippi","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2017.02.002_bb0085","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/10567","article-title":"Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses","volume":"5","author":"Fl\u00fcgel","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2017.02.002_bb0090","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1074-7613(01)00143-1","article-title":"Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis","volume":"14","author":"Fl\u00fcgel","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.nbd.2017.02.002_bb0095","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2017.02.002_bb0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ana.20875","article-title":"Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis","volume":"60","author":"Ifergan","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0105","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/brain\/awt023","article-title":"Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis","volume":"136","author":"Jolivel","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2017.02.002_bb0110","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2017.02.002_bb0115","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ana.21748","article-title":"Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis","volume":"66","author":"Kebir","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0120","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.4049\/jimmunol.1100626","article-title":"The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation","volume":"187","author":"Kofler","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.188.1.169","article-title":"B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice","volume":"188","author":"Litzenburger","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.nbd.2017.02.002_bb0130","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nm.3182","article-title":"A combination of fluorescent NFAT and H2B sensors uncovers dynamics of T cell activation in real time during CNS autoimmunity","volume":"19","author":"Lodygin","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2017.02.002_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/eji.200636745","article-title":"Faithful activation of an extra-bright red fluorescent protein in \u201cknock-in\u201d Cre-reporter mice ideally suited for lineage tracing studies","volume":"37","author":"Luche","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1044-5323(02)00125-2","article-title":"The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)","volume":"15","author":"Mahad","year":"2003","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0145","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ajpath.2012.05.011","article-title":"Kinetics of proinflammatory monocytes in a model of multiple sclerosis and its perturbation by laquinimod","volume":"181","author":"Mishra","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0150","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/acn3.67","article-title":"Laquinimod reduces neuroaxonal injury through inhibiting microglial activation","volume":"1","author":"Mishra","year":"2014","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0155","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nature11337","article-title":"T cells become licensed in the lung to enter the central nervous system","volume":"488","author":"Odoardi","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2017.02.002_bb0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0014-5793(97)00313-X","article-title":"\u2018Green mice\u2019 as a source of ubiquitous green cells","volume":"407","author":"Okabe","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2017.02.002_bb0165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archneur.59.3.391","article-title":"Migration of multiple sclerosis lymphocytes through brain endothelium","volume":"59","author":"Prat","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0170","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1177\/1352458512469698","article-title":"Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis","volume":"19","author":"Ruffini","year":"2013","journal-title":"Mult. Scler."},{"key":"10.1016\/j.nbd.2017.02.002_bb0175","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nature16939","article-title":"Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid","volume":"530","author":"Schl\u00e4ger","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2017.02.002_bb0180","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/7651_2014_150","article-title":"In vivo visualization of (auto)immune processes in the central nervous system of rodents","volume":"1304","author":"Schl\u00e4ger","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033797","article-title":"Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity","volume":"7","author":"Schulze-Topphoff","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2017.02.002_bb0190","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.it.2005.08.014","article-title":"Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis","volume":"26","author":"Steinman","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.20913","article-title":"How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis","volume":"60","author":"Steinman","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0200","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajpath.2011.09.037","article-title":"Modulation of autoimmune demyelination by laquinimod via induction of brain-derived neurotrophic factor","volume":"180","author":"Th\u00f6ne","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0205","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.201412147","article-title":"Brain barriers: crosstalk between complex tight junctions and adherens junctions","volume":"209","author":"Tietz","year":"2015","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0210","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jneuroim.2012.07.003","article-title":"Laquinimod modulates B cells and their regulatory effects on T cells in multiple sclerosis","volume":"251","author":"Toubi","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0215","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1191\/1352458504ms982oa","article-title":"Distinct roles for IP-10\/CXCL10 in three animal models, Theiler's virus infection, EAE, and MHV infection, for multiple sclerosis: implication of differing roles for IP-10","volume":"10","author":"Tsunoda","year":"2004","journal-title":"Mult. Scler."},{"key":"10.1016\/j.nbd.2017.02.002_bb0220","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00415-014-7264-4","article-title":"A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis","volume":"261","author":"Vollmer","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0225","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jneuroim.2014.08.621","article-title":"ALCAM and CD6\u2014multiple sclerosis risk factors","volume":"276","author":"Wagner","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0230","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.4049\/jimmunol.180.3.1565","article-title":"Th2 lymphoproliferative disorder of LatY136F mutant mice unfolds independently of TCR-MHC engagement and is insensitive to the action of Foxp3+ regulatory T cells","volume":"180","author":"Wang","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0235","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jneuroim.2010.07.009","article-title":"Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis","volume":"227","author":"Wegner","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0240","doi-asserted-by":"crossref","first-page":"8434","DOI":"10.4049\/jimmunol.180.12.8434","article-title":"Peripheral T cells are the therapeutic targets of glucocorticoids in experimental autoimmune encephalomyelitis","volume":"180","author":"W\u00fcst","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2017.02.002_bb0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2004.02.016","article-title":"Laquinimod (ABR-215062) suppresses the development of experimental autoimmune encephalomyelitis, modulates the Th1\/Th2 balance and induces the Th3 cytokine TGF-beta in Lewis rats","volume":"156","author":"Yang","year":"2004","journal-title":"J. Neuroimmunol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117300311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996117300311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T19:50:08Z","timestamp":1657137008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996117300311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":48,"alternative-id":["S0969996117300311"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2017.02.002","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Laquinimod enhances central nervous system barrier functions","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2017.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}